The SpectraCure PDT System with IDOSE® has the potential to become the tool that makes interstitial PDT accurate, precise and safe for each patient independent of the photosensitiser choice thanks to: Accuracy - The SpectraCure PDT System with IDOSE® has the potential to reduce treatment failures and enable the best possible treatment outcome of individual patients independent of tumour tissue variations. This is because the light dose from each individual optical fibre is monitored in real time together with other treatment-related parameters such as the oxygen and photosensitiser concentration to allow dose plan adjustment of each separate optical fibre.
Precision - The SpectraCure PDT System with IDOSE® is a truly a local treatment as it occurs only in the simultaneous presence of light, photosensitiser and oxygen.
Individualised dosimetry - tissue surrounding the localised treatment site is unaffected by The SpectraCure PDT System with IDOSE® because it is possible to monitor and adjust the light dose from each individual optical fibre. Safety -localised areas of cancer can be destroyed by The SpectraCure PDT System with IDOSE® without the cumulative toxicity associated with, e.g. ionizing radiation.